Table 1.
Study Phase |
Pre-randomization |
Randomization |
||
---|---|---|---|---|
Visit description (FU = follow-up, CO = close-out) | Screen | Baseline | FU | CO |
Visit number | 1 | 2 | 3 | 4 |
Visit week | −2 | 0 | 8 | 20 |
Informed consent, review inclusion/exclusion criteria | x | |||
Personal interveiw, medical history, medication use | x | |||
Office blood pressure (sitting + standing), vital signs | x | x | x | x |
Physical exam, height/weight, ECG | x | |||
Randomization | x | |||
Waist circumference, 6 min walk, blood collection | x | x | x | |
Accelerometry, assess adverse experiences | x | x | x | |
Diet recall, 4 m walk, grip strength | x | x | x | |
Short Phsyical Performance Battery | x | x |